The analysis of DHX30 stable or transient silencing (siDHX30-C or siDHX30C+M) was extended to U2OS (Figure S3A–D), osteosarcoma-derived cells that express relatively high levels of DHX30 [7]. Here, DHX30 is linked to osteosarcoma.